Emily Garnett - April 9, 2025 Seeing double: the rise of biparatopic antibodies It’s no secret that antibody therapies are gaining ever-increasing popularity in the pharmaceutical ...
Rebecca Tollervey - March 11, 2025 Innovations in antibody-drug conjugates and bispecific antibodies – what you need to know - a new special report We are delighted to release our latest report Innovations in antibody-drug conjugates and ...
Edward Couchman - March 11, 2025 Discontinuous Epitope Claims get Green Light in Europe Patents for antibodies defined by discontinuous epitopes have garnered a lot of attention recently. ...
Adam Gregory - March 7, 2025 Hummingbird Bioscience’s multi-payload ADC technology licensed by Callio Therapeutics We are delighted to congratulate our client Hummingbird Bioscience on the successful out-licensing ...
Camille Terfve - October 29, 2024 Alchemab: the art of AI antibody discovery Alchemab’s artificial intelligence platform enables the identification of antibodies for some of ...
Robert Andrews - August 20, 2024 Antibody-drug conjugates: the new frontier of cancer treatments Antibody-drug conjugates (ADCs) are big business. Big pharma is moving in, snapping up companies or ...
Adam Gregory - August 13, 2024 ‘It’s a 50% reduction in ageing’ Singapore startup VVB Bio promises a dramatic reduction in ageing via a single jab. Now out of ...
Rebecca Tollervey - July 16, 2024 EPO case law for antibodies – 2024 update In 2023 we published a pair of articles reviewing EPO case law in the field of antibodies, ...
Adam Gregory - July 15, 2024 Mewburn Ellis is proud to have worked on 26 of the 100 top-selling pharmaceuticals of 2023 Mewburn Ellis is proud to work with some of the world’s most globally significant pharmaceuticals, ...
Rebecca Brooks - February 29, 2024 Updates to the Guidelines for Examination at the EPO The Guidelines for Examination at the EPO (which will be referred to as “the Guidelines” in this ...
Rebecca Tollervey - February 22, 2024 Antibody inventions: Updates in the EPO Guidelines for Examination The EPO Guidelines for Examination are set to undergo updates effective from 1 March 2024. The ...
Amelia Jones - September 5, 2023 A leap forward in slowing down Alzheimer’s This summer has seen a major leap forward in slowing the rate of progression of Alzheimer’s disease.
David Brooks - July 19, 2023 Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022 Last year we reported the unprecedented growth of the innovative pharmaceuticals industry in 2021 ...
Rebecca Tollervey - May 9, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal: Part 2 – inventive step We have conducted a review of Board of Appeal decisions relating to antibody patents published ...
Rebecca Tollervey - February 1, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal The prosecution of patent applications relating to antibodies involves particular considerations. ...
Edward Couchman - November 11, 2022 Enablement Requirements for Antibody Claims to be Reviewed by US Supreme Court In a development which will be of interest to biotech companies, particularly those working in the ...
Adam Gregory - July 22, 2022 Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021 2021 was a year of unprecedented success for the biotech and pharmaceutical industries, with the ...
Tanis Keirstead - April 4, 2022 A much-needed boost: the future of coronavirus vaccines Just over two years after our first blog on Covid-19, it appears that the disease is here to stay. ...
Rebecca Tollervey - September 8, 2021 The other end of the antibody: Fc modifications as a focus for patent protection For us antibody nerds, a fascinating aspect of the development of monoclonal antibodies against ...
Chris Denison - March 5, 2021 Webinar - Antibody patenting practice at the EPO A new edition of the EPO Examination Guidelines came into force on 1 March 2021, including a new ...
Rebecca Tollervey - March 2, 2021 Patenting highly engineered antibodies in Europe In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Chris Denison - February 10, 2021 New EPO Guidelines for Examination of Antibody Inventions A new edition of the EPO examination guidelines will come into force on 1 March 2021. The EPO has ...
Adam Gregory - January 29, 2021 SARS-CoV-2 variants – reasons to be optimistic In recent weeks and months, several highly-transmissible variants of SARS-CoV-2 (the virus that ...
Eliot Ward - December 21, 2020 Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself? Respiratory viruses such as coronaviruses are notorious for evading the immune system[1] and, in ...
Rebecca Tollervey - October 30, 2020 Highly-engineered antibodies: evolving the patent strategy In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Adam Gregory - October 27, 2020 Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115 Our client, Hummingbird Bioscience, has received regulatory authorisation to initiate clinical ...
Rachel Oxley - July 9, 2020 “Test, test, test” – the importance of diagnostics in pandemic preparedness While the world waits for a vaccine to be developed and approved for use against the COVID-19 ...
Nick Sutcliffe - June 29, 2020 Supreme Court confirms strict line on insufficiency in the UK On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’ strict approach to sufficient ...
Rebecca Tollervey - June 25, 2020 Cellular immunity – a contributor to COVID-19 “dark matter”? Immunologist Karl Friston of University College London has theorized that there may be ...
Adam Gregory - May 15, 2020 New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...
Richard Clegg - May 14, 2020 Singapore's biotech breakthrough From the far east to the east coast of America, the world is taking note of a new energy surging ...
Rhiannon Wescott - May 1, 2020 Can a functionally defined patent claim ‘protect’ my medicinal product? From a patent perspective this may seem like a strange question with an obvious answer; “of ...
Adam Gregory - April 14, 2020 Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak In recent weeks there’s been a lot of discussion in the media of antibody tests relating to ...
Seán Walton - March 12, 2020 Oppositions & Appeals: We set the standard for the strawman Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)
Jane Liu - January 23, 2020 A promising target for new antibiotics In previous blogs we have discussed the global threat of antimicrobial resistance and some of the ...
Eliot Ward - December 6, 2019 Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...
Katherine Green - November 14, 2019 EPO oppositions: Nine key questions answered Mewburn Ellis has dug deep into a decade of EPO life sciences' decisions to discover fresh insights ...
Rebecca Tollervey - November 11, 2019 Top tips for patenting antibodies in Europe Antibody development is a mature field of technology. There are relatively few new targets, and the ...
Seán Walton - November 11, 2019 Oppositions a case to remember: we forced a fuller view of technical features Case 1 – T 1859/08 ( EPO Board of Appeal, 5 June 2016)
Katherine Green - October 30, 2019 Oppositions - a case to remember. Flexibility around added matter Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)
Richard Clegg - August 13, 2019 Challenges Post Selex Twenty-five years ago Tuerk and Gold reported the Selex method. Being the first European patent ...
Adam Gregory - December 10, 2018 Patent protection: five tips for biotech start-ups Early-stage biotech companies are often founded based on the exciting results of pre-clinical ...
Seán Walton - October 3, 2018 The pioneering work of Professor Sir Greg Winter Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of ...
